Diet is increasingly being researched as a potential intervention to slow, or even prevent, neurodegeneration in Parkinson’s ...

Veronica Brown lived with chronic fatigue, depression, and anxiety for over 10 years before she learned they were early signs ...

A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 ...

Research on stem cells is ongoing, but they're approved to treat a certain group of diseases. Here's what doctors say about ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Study suggests that preserved dopamine in certain brain regions may actually contribute to tremor symptoms, challenging ...

The Medical College of Wisconsin created a neurology department 50 years ago. Today with Froedtert it is world leader in neurological care, research.

Vesalius Therapeutics' deal with GSK centers around discovering and developing new treatments for Parkinson’s disease, and ...